Top Markets
Coin of the day
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
Rank in Stocks #40860
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
Share Price
$0.00312742
Last synced: 2024-10-01
Market Cap
$70.81K
Change (1 day)
-21.83%
Change (1 year)
0.00%
Country
SE
Trade Asarina Pharma AB (publ) (ASAP)

Category

Operating Margin for Asarina Pharma AB (publ) (ASAP)
Operating Margin as of August 2026 TTM: 0.00%
According to Asarina Pharma AB (publ) latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2022 the company had an Operating Margin of 0.00%.
Operating Margin history for Asarina Pharma AB (publ) from 2017 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.